Market Overview:
The global Ozagrel market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising demand for Ozagrel in research and medical applications, and increasing investments by key players in R&D activities. However, stringent regulatory norms may restrain the growth of the market. Based on type, the global Ozagrel market is segmented into min purity less than 98%, min purity 98%-99%, and min purity more than 99%. The min purity less than 98% segment is expected to account for a major share of the global Ozagrel market during the forecast period. This can be attributed to high demand for low-purity Ozagrel products from research institutes and universities across regions. Based on application, the global Ozagrel market is segmented into research, medical, and other applications.
Product Definition:
Ozagrel is a thromboxane A2 receptor antagonist that inhibits platelet aggregation and has anti-inflammatory effects. It is used to prevent blood clots in people at risk for heart attack or stroke.
Min Purity Less Than 98%:
Ozagrel is a new drug, which was approved by the U.S. FDA in 2016 for treatment of patients with advanced prostatic cancer and multiple myeloma who are intolerant to or who have progressed post-finishing radiation therapy. The drug has also been found to be effective in treating non-metastatic castration-resistant prostate cancer (nmCRPC).
Min Purity 98%-99%:
Min Purity 98%-99% is a medical-grade polypropylene glycol that has less than 2% free alcohol by volume. It is used in the preparation of Ozagrel, which is an OTC drug used for the treatment of Bleeding Ulcers and other skin conditions. According to FDA approved information, Min Purity 98%-99% has been found to be safe and effective for use in humans when consumed orally at doses up to 1 gram per day.
Application Insights:
Research application dominated the global ozagrel market in terms of revenue share in 2017. The growing need for innovative products with better efficiency and lower toxicity is expected to boost product demand for research applications over the forecast period.
Medical application is anticipated to witness significant growth over the forecast period owing to increasing product use as antifungal, antibiotic, antitumor and anti-inflammatory agent. In addition, new drug development using ozagrel as a platform molecule is expected to propel its demand in medical applications during future years.
Global pharmaceutical industry has witnessed tremendous growth due largely on account of innovations such as ¢â‚¬Å“3D printing¢â‚¬ technology which has revolutionized manufacturing process of drugs & medicines leading to reduced production costs.
Regional Analysis:
In terms of revenue, Asia Pacific dominated the global market in 2017. The presence of a large number of manufacturers coupled with increasing demand from emerging economies such as China and India is expected to drive the regional market over the forecast period. In addition, growing research activities by various universities in this region will also have a positive impact on industry growth.
The U.S., which was at par with Europe for ozagrel consumption, held majority shares owing to higher healthcare spending and R&D investments by pharmaceutical companies as compared to their European counterparts.
Growth Factors:
- Increasing geriatric population: The global geriatric population is expected to grow at a CAGR of 5.0% from 2016 to 2020, reaching nearly 1.5 billion by 2020. This growing population is susceptible to various age-related diseases such as heart disease, stroke, and Alzheimer’s disease, which will drive the demand for ozagrel products over the forecast period.
- Rising prevalence of cardiovascular diseases: The prevalence of cardiovascular diseases (CVD) is increasing globally due to changing lifestyles and dietary habits. According to the World Health Organization (WHO), CVD accounts for 31% of all global deaths each year and this number is projected to increase in the coming years owing to the aging population worldwide. This will create a high demand for ozagrel products as they are used in the treatment of CVDs.
Scope Of The Report
Report Attributes
Report Details
Report Title
Ozagrel Market Research Report
By Type
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
By Application
Research, Medical
By Companies
Cayman Chemical, Santa Cruz Biotechnology, LGC, LKT Laboratories, AbMole, Enzo Biochem, BOC Sciences, Selleck Chemicals, Clearsynth, BIOBERRY, Adooq Bioscience, APExBIO Technology, Aladdin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
174
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Ozagrel Market Report Segments:
The global Ozagrel market is segmented on the basis of:
Types
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research, Medical
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cayman Chemical
- Santa Cruz Biotechnology
- LGC
- LKT Laboratories
- AbMole
- Enzo Biochem
- BOC Sciences
- Selleck Chemicals
- Clearsynth
- BIOBERRY
- Adooq Bioscience
- APExBIO Technology
- Aladdin
Highlights of The Ozagrel Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Min Purity Less Than 98%
- Min Purity 98%-99%
- Min Purity More Than 99%
- By Application:
- Research
- Medical
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ozagrel Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ozagrel is a medication used to treat high blood pressure. Ozagrel belongs to a class of medications called angiotensin converting enzyme inhibitors (ACE inhibitors). It works by reducing the amount of blood pressure that your heart has to pump.
Some of the major players in the ozagrel market are Cayman Chemical, Santa Cruz Biotechnology, LGC, LKT Laboratories, AbMole, Enzo Biochem, BOC Sciences, Selleck Chemicals, Clearsynth, BIOBERRY, Adooq Bioscience, APExBIO Technology, Aladdin.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ozagrel Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Ozagrel Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Ozagrel Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Ozagrel Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Ozagrel Market Size & Forecast, 2020-2028
4.5.1 Ozagrel Market Size and Y-o-Y Growth
4.5.2 Ozagrel Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Min Purity Less Than 98%
5.2.2 Min Purity 98%-99%
5.2.3 Min Purity More Than 99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research
6.2.2 Medical
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ozagrel Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ozagrel Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Min Purity Less Than 98%
9.6.2 Min Purity 98%-99%
9.6.3 Min Purity More Than 99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research
9.10.2 Medical
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Min Purity Less Than 98%
10.6.2 Min Purity 98%-99%
10.6.3 Min Purity More Than 99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research
10.10.2 Medical
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Min Purity Less Than 98%
11.6.2 Min Purity 98%-99%
11.6.3 Min Purity More Than 99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research
11.10.2 Medical
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Min Purity Less Than 98%
12.6.2 Min Purity 98%-99%
12.6.3 Min Purity More Than 99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research
12.10.2 Medical
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Min Purity Less Than 98%
13.6.2 Min Purity 98%-99%
13.6.3 Min Purity More Than 99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research
13.10.2 Medical
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ozagrel Market: Competitive Dashboard
14.2 Global Ozagrel Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Cayman Chemical
14.3.2 Santa Cruz Biotechnology
14.3.3 LGC
14.3.4 LKT Laboratories
14.3.5 AbMole
14.3.6 Enzo Biochem
14.3.7 BOC Sciences
14.3.8 Selleck Chemicals
14.3.9 Clearsynth
14.3.10 BIOBERRY
14.3.11 Adooq Bioscience
14.3.12 APExBIO Technology
14.3.13 Aladdin
